Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF



GREY:TSTIF - Post by User

Post by echo2on Feb 22, 2018 11:41am
287 Views
Post# 27602163

Getinge States They Have Strengthened TSO3 Relationship!!

Getinge States They Have Strengthened TSO3 Relationship!!The important part of the Getinge PR (thanks for this!!!): STERIZONE VP4 is manufactured by TSO3 Inc. in Canada, an innovator in sterilization technology for medical devices in healthcare settings. Getinge has the exclusive distribution rights for STERIZONE VP4, and has since end-January 2018 strengthened this partnership where TSO3 Inc. will start to distribute the STERIZONE VP4 to defined customers in the United States and Canada. Low temperature sterilization is an important part of our offering for our customers and a strategic growth market for Getinge. We firmly believe that TSO3s leading-edge technology adds considerable value to our portfolio and this has been confirmed by the first STERIZONE VP4 installations in Europe. TSO3 has been working with us on site, supporting us all the way to ensure these first installations are a complete success, says Carsten Blecker, Chief Commercial Officer Getinge. Our goal is to establish a larger installed base and increased market share of the STERIZONE VP4, while accelerating adoption of the low temperature technology globally.
<< Previous
Bullboard Posts
Next >>